Skip to main content

Table 7 Results of the cost-effectiveness analysis

From: Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis

Group

Cost (CNY)

Incremental cost (CNY)

QALYs

Incremental QALY

ICER (CNY/QALY)

CH group

38,442.11

–

0.71959

–

–

DT group

42,300.26

3857.86

0.81686

0.09727

39,661.32